Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 299

Sort by

Sort Order Select

Journal Articles

Targeting CCL3+mono like LSC overcomes chemotherapy resistance in NPM1 mutant AML

Zhao Yin, Xi Jia, Sijian Yu, Xuan Li, Qifa Liu, Xi Xu

Blood (2025) 146 (Supplement 1): 3511.

https://doi.org/10.1182/blood-2025-3511

Published: 2025

Journal Articles

Novel risk stratification of ph-like ALL cohort receiving CD19-directed CAR-T therapy

Cai Zihong, Bailin He, Baiwei Luo, Zhixiang Wang, Wenhao Zhong, Xuan Zhou, Qifa Liu, Peng Li, Yong-xian Hu, Jing PAN, Liang Huang, Hongsheng Zhou

Blood (2025) 146 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2025-5108

Published: 2025

Journal Articles

Fecal microbiota transplantation ameliorates refractory chronic graft-versus-host disease through short-chain fatty acids-treg axis in allogeneic hematopoietic cell transplant recipients

Fen Huang, Qifa Liu

Blood (2025) 146 (Supplement 1): 7780.

https://doi.org/10.1182/blood-2025-7780

Published: 2025

Journal Articles

MSC affect the sensitivity of CML cells to TKIs through mitochondrial transfered via tunneling nanotubes

Zhechen Miao, Qiang WANG, Qifa Liu

Blood (2025) 146 (Supplement 1): 6758.

https://doi.org/10.1182/blood-2025-6758

Published: 2025

Journal Articles

Clinical study of single-center PDT-ALL-2016 regimen in the treatment of KMT2A-rearranged acute lymphoblastic leukemia

Jiaxin Zheng, Bailin He, Zhixiang Wang, Xuan Zhou, Wenhao Zhong, Qifa Liu, Hongsheng Zhou

Blood (2025) 146 (Supplement 1): 6866.

https://doi.org/10.1182/blood-2025-6866

Published: 2025

Journal Articles

Efficacy and safety of sorafenib combined with Standard Chemotherapy in adult patients with Myeloid sarcoma: A multi-center, cohort study

Qiuxiao Li, Xi Jia, Guopan Yu, Danian Nie, Ying Dong, Zhiqiang Sun, Chunju Wen, Jieyu Ye, Hui Liu, Hong Qu, Yu Zhang, Qifa Liu, Pengcheng Shi

Blood (2025) 146 (Supplement 1): 1670.

https://doi.org/10.1182/blood-2025-1670

Published: 2025

Journal Articles

Prospective evaluation of venetoclax combined with CLAG regimen in relapsed/refractory acute myeloid leukemia: A multicenter, randomized controlled, open-lable, phase II Trial

Guopan Yu, Yu Zhang, Weihua Zhao, Sijian Yu, Guangyang Weng, Dongsheng Wu, Wenjie Xiong, Danian Nie, Caixia Wang, Xiangjun Fu, Xuan Li, Qifa Liu

Blood (2025) 146 (Supplement 1): 1000.

https://doi.org/10.1182/blood-2025-1000

Published: 2025

Journal Articles

Clonal timing of FLT3-ITD dictates evolutionary trajectory and phenotypic heterogeneity in acute myeloid leukemia

Xu-Dong He, Mengfang Xia, Ruoyang Shao, Qifa Liu, Qian-Fei Wang

Blood (2025) 146 (Supplement 1): 988.

https://doi.org/10.1182/blood-2025-988

Published: 2025

Journal Articles

Synergistic effects of ASXL1 and BCOR on hematopoiesis and MDS/AML progression

Rongtao Xue, Yuting Qin, Ya Zhou, Xuan Li, Qifa Liu

Blood (2025) 146 (Supplement 1): 1462.

https://doi.org/10.1182/blood-2025-1462

Published: 2025

Journal Articles

Belumosudil for chronic graft-versus-host disease in children under 12: A retrospective analysis of effectiveness and safety

Jingtao Chen, Jianyun Liao, Fen Huang, Lan He, Fang Wang, Yuqian Xia, Chunfu Li, Qifa Liu

Blood (2025) 146 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2025-2467

Published: 2025

Journal Articles

Human intestinal acute graft-versus-host disease is governed by a subset of transition-like tissue-resident memory CD8+ T cells

Yiming Sun, Yutong Xue, Ruoyang Shao, Xinyu Liu, Chenyuyao Song, Zhiping Fan, Ren Lin, Na Xu, Qifa Liu, Hua Jin

Blood (2025) 146 (Supplement 1): 2453.

https://doi.org/10.1182/blood-2025-2453

Published: 2025

Journal Articles

Efficacy and Safety of cladribine combined with cytarabine and G-CSF in Eliminating Measurable Residual disease for Core-binding factor acute myeloid leukemia: A retrospective, single-arm, multicenter study

Qiuxiao Li, Xi Jia, Guopan Yu, Danian Nie, Ying Dong, Zhiqiang Sun, Chunju Wen, Jieyu Ye, Hui Liu, Hong Qu, Yu Zhang, Qifa Liu, Pengcheng Shi

Blood (2025) 146 (Supplement 1): 6968.

https://doi.org/10.1182/blood-2025-6968

Published: 2025

Journal Articles

Mutated and enucleated TIM3 regulates function of Acute Myeloid Leukemia stem cells through c-MYB

junwei huang, ningxin zhang, Xi Xu, Qifa Liu

Blood (2025) 146 (Supplement 1): 5280.

https://doi.org/10.1182/blood-2025-5280

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Sorafenib enhances anti-leukemia effect via promoting macrophage-NK cell immune crosstalk in FLT3-ITD+ AML patients receiving allo-HSCT

Ruoyang Shao, Peiru Chi, Yuxin Bai, Fang Dai, Tian Zhang, Zhonghui Jiang, Xi Xu, Xiaofeng Yang, Kejing Li, Guo Qiu, Yueyang Zhong, Na Xu, Fen Huang, Zhiping Fan, Ren Lin, Hua Jin, Jing Sun, Qifa Liu, Xuan Li

Blood (2025) 146 (Supplement 1): 2308.

https://doi.org/10.1182/blood-2025-2308

Published: 2025

Journal Articles

AML1/ETO upregulates fatty acid metabolism to induce venetoclax resistance in acute myeloid leukemia via activation of c-myc/SCD1 pathway

Zhao Yin, Zurong Yao, Dandan Chen, Qifa Liu, Baohong Ping, Guopan Yu

Blood (2025) 146 (Supplement 1): 6809.

https://doi.org/10.1182/blood-2025-6809

Published: 2025

Journal Articles

Neutrophil count is an independent prognostic indicator in early T-cell precursor lymphoblastic leukemia

Jieping Lin, Xiaoyuan Gong, Nanfang Zhuo, Chengming He, Yiming Cai, Zhixiang Wang, Xuan Zhou, Bailin He, Wenhao Zhong, Qifa Liu, Suning Chen, Yang Xu, Huafeng Wang, Ying Wang, Hongsheng Zhou

Blood (2025) 146 (Supplement 1): 6892.

https://doi.org/10.1182/blood-2025-6892

Published: 2025

Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2024-203334

Published: 2024

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Blood (2024) 144 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2024-205021

Published: 2024

Journal Articles

Pulmonary Dysfunction in Patients with Transfusion-Dependent Thalassemia

Xiao Liang, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhenbin Wei, Yumei Huang, Jing Bai, Yi Liang, Lingyuan Pan, Zhaoping Gan, Yu Lin, Yibin Yao, Ying Tang, Huicheng Huang, Xuemei Zhou, Qifa Liu, Yongrong Lai, Rongrong Liu

Blood (2024) 144 (Supplement 1): 1096.

https://doi.org/10.1182/blood-2024-204971

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Targeting CCL3+mono like LSC overcomes chemotherapy resistance in NPM1 mutant AML

Novel risk stratification of ph-like ALL cohort receiving CD19-directed CAR-T therapy

Fecal microbiota transplantation ameliorates refractory chronic graft-versus-host disease through short-chain fatty acids-treg axis in allogeneic hematopoietic cell transplant recipients

MSC affect the sensitivity of CML cells to TKIs through mitochondrial transfered via tunneling nanotubes

Clinical study of single-center PDT-ALL-2016 regimen in the treatment of KMT2A-rearranged acute lymphoblastic leukemia

Efficacy and safety of sorafenib combined with Standard Chemotherapy in adult patients with Myeloid sarcoma: A multi-center, cohort study

Prospective evaluation of venetoclax combined with CLAG regimen in relapsed/refractory acute myeloid leukemia: A multicenter, randomized controlled, open-lable, phase II Trial

Clonal timing of FLT3-ITD dictates evolutionary trajectory and phenotypic heterogeneity in acute myeloid leukemia

Synergistic effects of ASXL1 and BCOR on hematopoiesis and MDS/AML progression

Belumosudil for chronic graft-versus-host disease in children under 12: A retrospective analysis of effectiveness and safety

Human intestinal acute graft-versus-host disease is governed by a subset of transition-like tissue-resident memory CD8+ T cells

Efficacy and Safety of cladribine combined with cytarabine and G-CSF in Eliminating Measurable Residual disease for Core-binding factor acute myeloid leukemia: A retrospective, single-arm, multicenter study

Mutated and enucleated TIM3 regulates function of Acute Myeloid Leukemia stem cells through c-MYB

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Sorafenib enhances anti-leukemia effect via promoting macrophage-NK cell immune crosstalk in FLT3-ITD+ AML patients receiving allo-HSCT

AML1/ETO upregulates fatty acid metabolism to induce venetoclax resistance in acute myeloid leukemia via activation of c-myc/SCD1 pathway

Neutrophil count is an independent prognostic indicator in early T-cell precursor lymphoblastic leukemia

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Pulmonary Dysfunction in Patients with Transfusion-Dependent Thalassemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only